Consumer Health Cancer / Immunology

Ascentage Pharma's Three Studies Highlight New Potential Indications

  "The data we presented at this year's AACR Annual Meeting highlight the three drug candidates' potential for clinical development and promising syn...

 April 18, 2023 | News

Roche's Tecentriq plus Avastin Reduces Cancer Return Risk in Phase III Liver Cancer Study

In the first-ever positive Phase III trial in the adjuvant hepatocellular carcinoma (HCC) setting, Tecentriq plus Avastin reduced the...

 April 17, 2023 | News

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

"We at ImmunOs are very satisfied with the work done by ProBioGen. We highly appreciate the collaborative partnership with ProBioGen and the team's dedicat...

 April 13, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

 April 12, 2023 | News

BGI Global's Colorectal Cancer Survey uncovers gaps in awareness and concerns over affordability

This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...

 April 07, 2023 | News

Chula Develops CAR T-Cell Therapy for Thai Lymphoma Patients

Chulalongkorn University and the Faculty of Medicine, Chulalongkorn University, organized the 17th Chula the Impact on "CAR T-Cell Canc...

 April 06, 2023 | News

Roche Diagnostics India Unveils #BeYourOwnShero Campaign to Educate Women About Cervical Cancer Prevention

Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. D...

 April 05, 2023 | News

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

 March 14, 2023 | News

Akeso, based in Hong Kong, completes patient enrollment for Phase III clinical trial of Cadonilimab in the treatment of gastric cancer.

Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab (PD-1/CTLA-4 bi-sp...

 March 14, 2023 | News

Qritive and Corista Partner to Advance Computational Digital Pathology Workflows with Integrated Image Management"

Through the partnership, Qritive's artificial intelligence modules and Corista's DP3® image management platform will be integrated to help pathologist'...

 March 14, 2023 | News

Porton Advanced and Bennu Biotherapeutics Partner to Develop Cell Therapy for Solid Tumors

As an end-to-end gene and cell therapy service CDMO, Porton Advanced provides comprehensive solutions covering plasmids, cell therapy, gene therapy, oncoly...

 March 13, 2023 | News

Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EAU

Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

 March 09, 2023 | News

Hummingbird Bioscience licenses Cancer Research UK's clinical trial results to support HMBD-001 development.

The Phase 1/2a clinical trial in the United Kingdom is being sponsored and managed by CRUK's Centre for Drug Development and led by Chief Investi...

 March 06, 2023 | News

C2i Genomics Expands to Japan, Announces Collab with Riken Genesis

The collaboration will expand C2i’s global reach and bring MRD cancer monitoring capabilities for solid tumors to Japan     C2i Genomics...

 March 03, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close